Abstract
Objective: Treatment of chronic functional constipation is difficult. Both oral and topical laxatives may fail to adequately relieve symptoms, and there is risk of adverse effects such as functional or structural changes in the intestine, together with electrolyte disturbances. The aim of this study was to evaluate the efficacy and safety of a suppository that combines sodium bicarbonate and potassium bitartrate in a polyethylene glycol base to generate approximately 175mL of carbon dioxide (CO2). This release distends the rectal ampulla, thereby stimulating peristalsis and a subsequent bowel movement.
Patients and methods: This was a prospective, crossover, double-blind, randomised, placebo-controlled, sequential study of outpatients with chronic functional constipation. Each patient received two suppositories of identical appearance, containing active drug or placebo. The sequence of active drug-placebo (sequence 1) or placebo-active drug (sequence 2) was randomised in groups of eight. The second suppository was taken 7 days after the first. The following parameters were evaluated and scored: evacuation time, type of evacuation, feeling of emptying of the rectal ampulla, stool characteristics, anal complaints, abdominal pain and overall patient assessment.
Results: A total of 29 patients entered the study. According to a restricted sequential plan, a statistical significance (p < 0.05) in favour of the active drug was reached after 26 patients. A positive response within 30 minutes of introduction of the suppository occurred in 51.7% and 6.9% of patients treated with the active drug and placebo, respectively (p = 0.0003). Normal evacuation occurred in 65.5% and 24.1% of patients treated with the active drug and placebo, respectively (p = 0.004). Normal stool consistency was found in 44.8% and 7.2% of patients treated with the active drug and placebo, respectively (p = 0.04). Patient assessment of treatment as satisfactory occurred in 51.7% and 20.7% of subjects treated with the active drug and placebo, respectively (p = 0.029). Only a trend in favour of the active drug was observed with regard to feeling of incomplete evacuation, and active drug was comparable to placebo with regard to anal and abdominal tolerability
Conclusion: The CO2-releasing suppository may represent an alternative to rectal laxatives for the relief of chronic functional constipation. The data obtained in this study indicate that CO2-releasing suppositories may be usefully and safely employed in the treatment of patients at risk for electrolyte disorders such as the elderly or patients with renal or cardiovascular disorders.
Similar content being viewed by others
Notes
The use of trade names is for product identification purposes only and does not imply endorsement.
References
Xing JH, Soffer EE. Adverse effects of laxatives. Dis Colon Rectum 2001; 44: 1201–9
Schiller LR. Review: the therapy of constipation. Aliment Pharmacol Ther 2001; 15: 749–63
Nir-Paz R, Cohen R, Haviv YS. Acute hyperphosphatemia caused by sodium phosphate enema in a patient with liver dysfunction and chronic renal failure. Ren Fail 1999; 21: 541–4
Hakata T, Hijma M, Okabe T, et al. Methods of evaluation of release of carbon dioxide from effervescent suppositories. Chem Pharm Bull 1993; 41: 346–50
Hakata T, Hijma M, Kimura S, et al. Effects of bases and additives on release of carbon dioxide from effervescent suppositories. Chem Pharm Bull 1993; 41: 351–6
Thompson WG, Creed DA, Drossman DA, et al. Functional bowel disease and abdominal pain. Gastroenterol Int 1992; 5: 75–91
Armitage P. Sequential methods in clinical trials. Am J Public Health 1958; 48: 1395–402
Graham DY, Moser SE, Estes MK. The effect of bran on bowel function in constipation. Am J Gastroenterol 1982; 77: 599–603
Preston DM, Lennard-Jones JE. Severe chronic constipation of young women: idiopathic slow transit constipation. Gut 1986; 27: 41–8
Turnbull GK, Lennard-Jones JE, Bartram CI. Failure of rectal expulsion as a cause of constipation: why fibre and laxatives sometimes fail. Lancet 1986; I: 767–9
Klauser AG, Peyerl C, Schindlbeck NE, et al. Nutrition and physical activity in chronic constipation. Eur J Gastroenterol Hepatol 1992; 4: 227–33
Muller-Lissner SA. Constipation and the irritable bowel syndrome. Eur J Gastroenterol Hepatol 1993; 5: 587–92
Lennard Jones JE. Medical treatment of constipation. In: Barbara L, Corinaldesi R, Gizzi G, et al., editors. Chronic constipation. London: Saunders, 1996: 178–94
Baker EH, Sandle GI. Complications of laxative abuse. Annu Rev Med 1996; 47: 127–34
Meiser JL, Bergman D, Graney D, et al. Human rectal mucosa: proctoscopic and morphological changes caused by laxatives. Gastroenterology 1977; 72: 1274–9
Spinrad S, Grosskopf Y, Blum I, et al. Treating constipation with phosphate enema: an unnecessary risk. Isr J Med Sci 1989; 25: 237–8
Rohack JJ, Metha BR, Subramanyam K. Hyperphosphatemia and hypocalcemic coma associated with phosphate enema. South Med J 1985; 78: 1241–2
Acknowledgements
This study was supported by a research grant from Promefarm Co., Milan, Italy.
The authors have no potential conflicts of interest that are directly relevant to the contents of this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lazzaroni, M., Casini, V. & Porro, G.B. Role or Carbon Dioxide-Releasing Suppositories in the Treatment of Chronic Functional Constipation. Clin. Drug Investig. 25, 499–506 (2005). https://doi.org/10.2165/00044011-200525080-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00044011-200525080-00002